304 related articles for article (PubMed ID: 27688081)
1. TERT Promoter Mutation in an Aggressive Cribriform Morular Variant of Papillary Thyroid Carcinoma.
Oh EJ; Lee S; Bae JS; Kim Y; Jeon S; Jung CK
Endocr Pathol; 2017 Mar; 28(1):49-53. PubMed ID: 27688081
[TBL] [Abstract][Full Text] [Related]
2. Cribriform-morular variant of papillary thyroid carcinoma: a study of 3 cases featuring the PIK3CA mutation.
Kwon MJ; Rho YS; Jeong JC; Shin HS; Lee JS; Cho SJ; Nam ES
Hum Pathol; 2015 Aug; 46(8):1180-8. PubMed ID: 26054797
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic and molecular features of cribriform morular variant of papillary thyroid carcinoma].
Cui XJ; Zhao HO; Su P; Chen J; Zhang RY; Pan Y; Ouyang XM; Liu J; Zhang JQ; Yang Y; Yang R; Ding L; Liu ZY
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):354-359. PubMed ID: 29783802
[No Abstract] [Full Text] [Related]
4. Classic Architecture with Multicentricity and Local Recurrence, and Absence of TERT Promoter Mutations are Correlates of BRAF (V600E) Harboring Pediatric Papillary Thyroid Carcinomas.
Onder S; Ozturk Sari S; Yegen G; Sormaz IC; Yilmaz I; Poyrazoglu S; Sanlı Y; Giles Senyurek Y; Kapran Y; Mete O
Endocr Pathol; 2016 Jun; 27(2):153-61. PubMed ID: 26951110
[TBL] [Abstract][Full Text] [Related]
5. Cribriform-morular variant of papillary thyroid carcinoma: a distinctive type of thyroid cancer.
Lam AK; Saremi N
Endocr Relat Cancer; 2017 Apr; 24(4):R109-R121. PubMed ID: 28314770
[TBL] [Abstract][Full Text] [Related]
6. Cribriform-morular variant of papillary thyroid carcinoma.
Pradhan D; Sharma A; Mohanty SK
Pathol Res Pract; 2015 Oct; 211(10):712-6. PubMed ID: 26293799
[TBL] [Abstract][Full Text] [Related]
7. TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Liu X; Qu S; Liu R; Sheng C; Shi X; Zhu G; Murugan AK; Guan H; Yu H; Wang Y; Sun H; Shan Z; Teng W; Xing M
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1130-6. PubMed ID: 24617711
[TBL] [Abstract][Full Text] [Related]
8. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Gandolfi G; Ragazzi M; Frasoldati A; Piana S; Ciarrocchi A; Sancisi V
Eur J Endocrinol; 2015 Apr; 172(4):403-13. PubMed ID: 25583906
[TBL] [Abstract][Full Text] [Related]
9. Cribriform-morular variant of papillary thyroid carcinoma at pediatric age - case report and review of the literature.
Brehar AC; Terzea DC; Ioachim DL; Procopiuc C; Brehar FM; Bulgăr AC; Ghemigian MV; Dumitrache C
Rom J Morphol Embryol; 2016; 57(2):531-7. PubMed ID: 27516030
[TBL] [Abstract][Full Text] [Related]
10. Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Vuong HG; Altibi AM; Duong UN; Ngo HT; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
Tumour Biol; 2017 Oct; 39(10):1010428317713913. PubMed ID: 29037127
[TBL] [Abstract][Full Text] [Related]
11. TERT Promoter Mutations and Tumor Persistence/Recurrence in Papillary Thyroid Cancer.
Myung JK; Kwak BK; Lim JA; Lee MC; Kim MJ
Cancer Res Treat; 2016 Jul; 48(3):942-7. PubMed ID: 26727717
[TBL] [Abstract][Full Text] [Related]
12. Aggressive cribriform-morular variant of papillary thyroid carcinoma: Report of an unusual case with pulmonary metastasis displaying poorly differentiated features.
Tsuji H; Yasuoka H; Nakamura Y; Hirokawa M; Hiroshima T; Sakamaki Y; Miyauchi A; Tsujimoto M
Pathol Int; 2018 Dec; 68(12):700-705. PubMed ID: 30376202
[TBL] [Abstract][Full Text] [Related]
13. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract][Full Text] [Related]
14. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
[TBL] [Abstract][Full Text] [Related]
15. BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.
Jin L; Chen E; Dong S; Cai Y; Zhang X; Zhou Y; Zeng R; Yang F; Pan C; Liu Y; Wu W; Xing M; Zhang X; Wang O
Oncotarget; 2016 Apr; 7(14):18346-55. PubMed ID: 26943032
[TBL] [Abstract][Full Text] [Related]
16. Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT.
Dettmer MS; Schmitt A; Steinert H; Capper D; Moch H; Komminoth P; Perren A
Endocr Relat Cancer; 2015 Jun; 22(3):419-29. PubMed ID: 25870252
[TBL] [Abstract][Full Text] [Related]
17. Progression of Papillary Thyroid Carcinoma to Anaplastic Carcinoma in Metastatic Lymph Nodes: Solid/Insular Growth and Hobnail Cell Change in Lymph Nodes Are Predictors of Subsequent Anaplastic Transformation.
Odate T; Oishi N; Kawai M; Tahara I; Mochizuki K; Akaishi J; Ito K; Katoh R; Kondo T
Endocr Pathol; 2021 Sep; 32(3):347-356. PubMed ID: 33761111
[TBL] [Abstract][Full Text] [Related]
18. Control of Lung Metastases and Colon Polyposis with Lenvatinib Therapy in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma and an
Ito Y; Ishikawa H; Kihara M; Hirokawa M; Kiyota N; Kasahara T; Miyauchi A
Thyroid; 2019 Oct; 29(10):1511-1517. PubMed ID: 31317827
[No Abstract] [Full Text] [Related]
19. Characteristics of cribriform morular variant of papillary thyroid carcinoma in post-Chernobyl affected region.
Lam AK; Fridman M
Hum Pathol; 2018 Apr; 74():170-177. PubMed ID: 29320754
[TBL] [Abstract][Full Text] [Related]
20. TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.
Melo M; Gaspar da Rocha A; Batista R; Vinagre J; Martins MJ; Costa G; Ribeiro C; Carrilho F; Leite V; Lobo C; Cameselle-Teijeiro JM; Cavadas B; Pereira L; Sobrinho-Simões M; Soares P
J Clin Endocrinol Metab; 2017 Jun; 102(6):1898-1907. PubMed ID: 28323937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]